Blue Origin Launches Suborbital
Mission Sending Central Florida Couple Back to Space (Sources:
Orlando Sentinel, Blue Origin)
Winter Park power couple Marc and Sharon Hagle returned to space on a
short suborbital flight aboard Blue Origin's New Shepard rocket on
Friday. Blue Origin successfully completed its ninth human spaceflight
and the 28th flight for the New Shepard program on Friday from the
company's Texas site. (11/22)
New Glenn Rocket Rises on Florida Pad
Ahead of 1st Launch (Source: Space.com)
Blue Origin's powerful new orbital rocket has risen on the launch pad
to prep for a debut flight that could happen soon. New Glenn was
stacked at Launch Complex 36 at Cape Canaveral Space Force Station in
Florida, which is next door to NASA's Kennedy Space Center. Blue Origin
has not announced an official launch date for the big new rocket, but
media reports have suggested it could occur in late 2024. (11/22)
China’s New Hypergravity Machine Can
Produce 1,900 Times Earth’s Gravity (Source: BGR)
China has taken a monumental leap in scientific research by activating
the world’s most advanced hypergravity machine. the Centrifugal
Hypergravity and Interdisciplinary Experiment Facility (CHIEF). CHIEF
is a groundbreaking system located in Hangzhou, Zhejiang province,
which will house the largest hypergravity centrifuge ever built. When
fully operational, CHIEF will be capable of producing forces thousands
of times stronger than Earth’s gravity. China says this will completely
revolutionize research and science of extreme conditions. (11/22)
Trump Picks Former Space Coast
Congressman to Lead CDC (Source: Reuters)
Donald Trump on Friday announced Dave Weldon, a former congressman and
a medical doctor, as his choice for director of the Centers for Disease
Control and Prevention, a sweeping agency with a $17.3 billion budget
used as a public health model around the world. The CDC tracks and
responds to infectious disease outbreaks, including recommending
licensed vaccines such as routine vaccines used in childhood and those
given during the COVID-19 pandemic. (11/22)
No comments:
Post a Comment